BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 31178141)

  • 21. Using Oct4:MerCreMer Lineage Tracing to Monitor Endogenous Oct4 Expression During the Reprogramming of Fibroblasts into Induced Pluripotent Stem Cells (iPSCs).
    Greder LV; Post J; Dutton JR
    Methods Mol Biol; 2016; 1357():97-110. PubMed ID: 25687297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A defined xeno-free and feeder-free culture system for the derivation, expansion and direct differentiation of transgene-free patient-specific induced pluripotent stem cells.
    Lu HF; Chai C; Lim TC; Leong MF; Lim JK; Gao S; Lim KL; Wan AC
    Biomaterials; 2014 Mar; 35(9):2816-26. PubMed ID: 24411336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attempts for deriving extended pluripotent stem cells from common marmoset embryonic stem cells.
    Yoshimatsu S; Nakajima M; Sonn I; Natsume R; Sakimura K; Nakatsukasa E; Sasaoka T; Nakamura M; Serizawa T; Sato T; Sasaki E; Deng H; Okano H
    Genes Cells; 2023 Feb; 28(2):156-169. PubMed ID: 36530170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
    Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolome Profiling of Partial and Fully Reprogrammed Induced Pluripotent Stem Cells.
    Park SJ; Lee SA; Prasain N; Bae D; Kang H; Ha T; Kim JS; Hong KS; Mantel C; Moon SH; Broxmeyer HE; Lee MR
    Stem Cells Dev; 2017 May; 26(10):734-742. PubMed ID: 28346802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transgene-free iPSCs generated from small volume peripheral blood nonmobilized CD34+ cells.
    Merling RK; Sweeney CL; Choi U; De Ravin SS; Myers TG; Otaizo-Carrasquero F; Pan J; Linton G; Chen L; Koontz S; Theobald NL; Malech HL
    Blood; 2013 Apr; 121(14):e98-107. PubMed ID: 23386128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel embryonic stem cell line derived from the common marmoset monkey (Callithrix jacchus) exhibiting germ cell-like characteristics.
    Müller T; Fleischmann G; Eildermann K; Mätz-Rensing K; Horn PA; Sasaki E; Behr R
    Hum Reprod; 2009 Jun; 24(6):1359-72. PubMed ID: 19251728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic mRNA Reprogramming of Human Fibroblast Cells.
    Liu J; Verma PJ
    Methods Mol Biol; 2015; 1330():17-28. PubMed ID: 26621585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of Footprint-Free Induced Pluripotent Stem Cells from Human Fibroblasts Using Episomal Plasmid Vectors.
    Ovchinnikov DA; Sun J; Wolvetang EJ
    Methods Mol Biol; 2015; 1330():37-45. PubMed ID: 26621587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Insight into DNA-free Reprogramming Approaches to Generate Integration-free Induced Pluripotent Stem Cells for Prospective Biomedical Applications.
    Borgohain MP; Haridhasapavalan KK; Dey C; Adhikari P; Thummer RP
    Stem Cell Rev Rep; 2019 Apr; 15(2):286-313. PubMed ID: 30417242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of transgene-free mouse induced pluripotent stem cells using an excisable lentiviral system.
    Varga E; Nemes C; Davis RP; Ujhelly O; Klincumhom N; Polgar Z; Muenthaisong S; Pirity MK; Dinnyes A
    Exp Cell Res; 2014 Apr; 322(2):335-44. PubMed ID: 24560743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of human β-thalassemia induced pluripotent cell lines by reprogramming of bone marrow-derived mesenchymal stromal cells using modified mRNA.
    Varela I; Karagiannidou A; Oikonomakis V; Tzetis M; Tzanoudaki M; Siapati EK; Vassilopoulos G; Graphakos S; Kanavakis E; Goussetis E
    Cell Reprogram; 2014 Dec; 16(6):447-55. PubMed ID: 25354259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of pluripotency in long-term cryopreserved human neonatal fibroblasts in feeder-free condition.
    Csobonyeiova M; Krajciova L; Nicodemou A; Polak S; Danisovic L
    Cell Tissue Bank; 2017 Mar; 18(1):45-52. PubMed ID: 27873029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reprogramming human somatic cells into induced pluripotent stem cells (iPSCs) using retroviral vector with GFP.
    Kim KY; Hysolli E; Park IH
    J Vis Exp; 2012 Apr; (62):. PubMed ID: 22491226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of Human iPSCs by Reprogramming with the Unmodified Synthetic mRNA.
    Annand RR
    Methods Mol Biol; 2021; 2239():163-174. PubMed ID: 33226619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of pluripotent stem cells by reprogramming human ocular fibroblasts under xeno-free conditions.
    Xiong Y; Liu Y; Ge J
    Arq Bras Oftalmol; 2018; 81(5):376-383. PubMed ID: 30208139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of Induced Pluripotent Stem Cells (iPSCs) from Adult Canine Fibroblasts.
    Koh S; Piedrahita JA
    Methods Mol Biol; 2015; 1330():69-78. PubMed ID: 26621590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. mRNA Reprogramming of T8993G Leigh's Syndrome Fibroblast Cells to Create Induced Pluripotent Stem Cell Models for Mitochondrial Disorders.
    Grace HE; Galdun P; Lesnefsky EJ; West FD; Iyer S
    Stem Cells Dev; 2019 Jul; 28(13):846-859. PubMed ID: 31017045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Derivation of Equine-Induced Pluripotent Stem Cell Lines Using a piggyBac Transposon Delivery System and Temporal Control of Transgene Expression.
    Nagy K; Nagy A
    Methods Mol Biol; 2015; 1330():79-88. PubMed ID: 26621591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment of Transgene-Free Porcine Induced Pluripotent Stem Cells.
    Conrad JV; Neira JA; Rusteika M; Meyer S; Clegg DO; Chu LF
    Curr Protoc; 2024 May; 4(5):e1012. PubMed ID: 38712688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.